USP panel remands revised compounding standards for further review

Mar 12, 2020 - 02:33 PM

The United States Pharmacopeia Appeals Panel today remanded the revised USP General Chapter standards <795> for nonsterile compounding and <797> for sterile compounding to an expert committee “for further engagement on the issues raised concerning the beyond-use date provisions.” USP last year postponed the effective dates for these standards and for the new General Chapter <825> radiopharmaceuticals standard due to pending appeals. The appeals panel today denied the General Chapter <825> appeal, encouraging the appellant to submit a narrower request for revision to the expert committee. AHA had urged USP to delay the <797> standard due to implementation and compliance concerns. 

Today’s announcement will delay the effective date of the revised <797> chapter, as well as the effective date of General Chapter <800> on hazardous drug handling in health care settings. While <800> will remain informational pending final revisions to <797>, AHA advises members to contact their state boards of pharmacy regarding state-level effective dates for General Chapter <800>. AHA will update members with additional information as it becomes available.  
 

Related News Articles

Headline
AHA podcast discusses importance of elevating the patient voice to strengthen care quality, trust
In this conversation, Caroline DeLongchamps, director of the patient- and family-centered care program at MUSC Health, shares a powerful personal story and…
Headline
New AHA issue brief available on incorporating care navigation and coordination
The AHA Aug. 11 published a new issue brief on how hospitals and health systems can incorporate care navigation and coordination into their patient care…
Headline
Two people die in Michigan from cyclosporiasis outbreak
Two individuals have died in Michigan in connection to the current multistate cyclosporiasis outbreak, the Michigan Department of Health and Human Services…
Headline
AHA releases report on rural sepsis care
The AHA’s Living Learning Network, in partnership with the Centers for Disease Control and Prevention, July 22 released “Rural Sepsis Care in Action: Real-…
Blog
What AHA’s Affordability Recommendations Mean for Employers
Public
In our previous blog, we examined what the AHA’s affordability recommendations could mean for patients. Now we turn to another critical stakeholder group:…
Headline
CDC issues advisory to healthcare providers on cyclosporiasis cases
The Centers for Disease Control and Prevention July 14 released an advisory on the growing cyclosporiasis cases across the U.S. The advisory said that the…